JAMES LAWRENCE: Open Payments
NPI 1669657896 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,434 in 56 payments from 12 companies in 2025. Trend: 2023 $1,723 · 2024 $2,597 · 2025 $1,434
Food & beverage: $1,434
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $337 |
| ANI Pharmaceuticals, Inc. | 11 | $213 |
| ABBVIE INC. | 12 | $202 |
| Janssen Biotech, Inc. | 4 | $177 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $124 |
| Aurinia Pharma U.S., Inc. | 5 | $115 |
| AstraZeneca Pharmaceuticals LP | 5 | $106 |
| Mallinckrodt Hospital Products Inc. | 2 | $70 |
| Amgen Inc. | 2 | $36 |
| Gilead Sciences, Inc. | 1 | $22 |
Products named: BENLYSTA, PURIFIED CORTROPHIN GEL, TREMFYA, RINVOQ, LUPKYNIS, SAPHNELO, SKYRIZI, OFEV.
Industry payments across AL — which companies pay providers there.
